Neurophysiological Study of Sensory and Cognitive Processes in Healthy Children and Adults

NCT ID: NCT03182400

Last Updated: 2022-09-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

450 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-06-14

Study Completion Date

2027-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is now widely accepted that autism is linked to a developmental disorder and cerebral function.

Our research team (UMR U930 INSERM, François-Rabelais University of Tours, whom Pr F Bonnet-Brilhault is responsible for team "Autism") hypothesizes that atypical sensory information processing, especially auditory and / or visual information, could underly the symptoms observed in autism. A better knowledge of the typical development of the sensory and cognitive processes must therefore make it possible in the long term to identify the abnormalities linked to the autism spectrum disorders (ASD).

Studies in healthy subjects are therefore necessary in order to identify neurophysiological indices of cerebral functioning and to study their evolution during normal development, making it possible in the future to compare with populations of subjects with ASD.

The investigators intend to study the development of all the cognitive processes involved in the processing of sensory and, in particular, auditory and visual information in humans: from low-level perception processes to higher-level cognitive processes (attention, emotion, language, prediction, ...). For this the investigators will use non-invasive neurophysiological explorations (EEG, eye tracking) as well as neuropsychological explorations (Questionnaires or spontaneous language recording).

A better understanding of the pathophysiological mechanisms underlying the symptoms observed in autism could ultimately lead to the development of new specific therapeutic strategies, particularly in the field of exchange and development therapy or cognitive remediation .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Volunteer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy volunteer

Neurophysiological assessment Neuropsychological assessment

Group Type EXPERIMENTAL

Neurophysiological assessment

Intervention Type BEHAVIORAL

Assessment of cerebral electrical activity Assessment of ocular exploration Neurovegetative assessments

Neuropsychological assessment

Intervention Type BEHAVIORAL

sub-tests, scales, surveys, reaction time measurement

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neurophysiological assessment

Assessment of cerebral electrical activity Assessment of ocular exploration Neurovegetative assessments

Intervention Type BEHAVIORAL

Neuropsychological assessment

sub-tests, scales, surveys, reaction time measurement

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Between 1 and 60 years-old
* Able to understand and apply instructions for a task
* Information of subject or legal representant
* Informed written consent of subject or legal representant
* Affiliation to the social security system

Exclusion Criteria

* Abnormal corrected vision
* Abnormal audition
* Known personal neurological pathology
* Known personal psychiatric problems
* Identified difficulties for walking, language, or learning
* Exclusion period because of participation to another experimental protocol
* Adult with legal protection
Minimum Eligible Age

1 Year

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Tours

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chru Tours

Tours, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Frederique Bonnet-Brilhault, PhD

Role: CONTACT

0247473846

Marie Gomot

Role: CONTACT

0247478664

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marie Gomot

Role: primary

0247478664

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PHAO17-FBB/PROSCEA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Agency in Dystonia
NCT03351218 COMPLETED NA